Drug intelligence / Profile preview

IB004

Development stage
Preclinical
Lead developer
Interactome Biotherapeutics
Modality
Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Systemic, Intraoral, Topical, Intranasal
01

Overview

IB004 is an early-stage therapeutic candidate being developed by Interactome Biotherapeutics, utilizing small extracellular vesicles (sEVs), commonly referred to as exosomes. The drug is produced using the company's proprietary Native Nano Platform, which aims to harness the natural biological properties of exosomes for therapeutic delivery or intercellular communication. Currently in the discovery phase, the specific molecular targets, active ingredients, and primary therapeutic indications for IB004 remain undisclosed by the developer. It represents part of an emerging class of exosome-based therapies designed to address unmet medical needs through novel regenerative or modulatory mechanisms.

Brand names
AdvilMotrinIBUMotrin IB
Other names
IB4IB-4IB 4
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on IB004.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on IB004.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call